[Cancer unmasked or provoked by immunosuppressive therapy]

Area of Science:

• Oncology
• Dermatology
• Immunology

Background:

• The link between immunosuppressive therapy and cancer risk is under investigation.
• Certain skin conditions, such as vasculitis and pyoderma gangrenosum, have known associations with cancer.

Observation:

• Two cases are presented where patients developed cancer shortly after initiating immunosuppressive therapy for skin manifestations.
• The skin conditions were vasculitis and pyoderma gangrenosum.

Findings:

• Immunosuppressive treatment for vasculitis and pyoderma gangrenosum may unmask or provoke underlying malignancies.
• The study highlights a potential iatrogenic risk of immunosuppression in susceptible individuals.

Implications:

• Clinicians should consider the potential for unmasking cancer when prescribing immunosuppressive therapy for inflammatory skin diseases.
• Further investigation into the precise mechanisms and overall risk is warranted to inform clinical practice and patient management.